Brief: Alimera Sciences Reports First Quarter 2023 Results
15/05/2023 12:56
Alimera Sciences Inc ALIM.O :
* ALIMERA SCIENCES REPORTS FIRST QUARTER 2023 RESULTS
* ALIMERA SCIENCES INC - QTRLY LOSS PER SHARE $0.71
* ALIMERA SCIENCES INC - QTRLY CONSOLIDATED NET REVENUE OF
$13.5
MILLION UP 14% VERSUS. Q1 OF 2022
* ALIMERA SCIENCES - AS OF MARCH 31, 2023, HAD CASH AND CASH
EQUIVALENTS OF ABOUT$13.1 MILLION
Source text for Eikon: ID:nGNX4r8KWf
Further company coverage: ALIM.O
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger